Therapeutic trial of immunosuppressive agents in multiple sclerosis.
D001219:Aspartate Aminotransferases / Q000097:blood; D001806:Blood Urea Nitrogen; D002986:Clinical Trials as Topic; D005069:Evaluation Studies as Topic; D006801:Humans; D005779:Immunodiffusion; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D007136:Immunoglobulins / Q000032:analysis; D015122:Mercaptopurine / Q000627:therapeutic use*; D008727:Methotrexate / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000201:enzymology / Q000276:immunology; D010919:Placebos
D007074:Immunoglobulin G; D007075:Immunoglobulin M; D007136:Immunoglobulins; D010919:Placebos; D015122:Mercaptopurine; D001219:Aspartate Aminotransferases; D008727:Methotrexate